| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.16 | 0.003 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.16 | 0.004 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.098 | 0.004 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.004 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.005 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.095 | 0.006 |